Fny Investment Advisers, LLC Standard Biotools Inc. Transaction History

Fny Investment Advisers, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$1.6 - $3.99 $12,800 - $31,920	-8,000 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$2.8 - $3.96 $8,400 - $11,880	3,000 Added 60.0%	8,000 $28,000
Q4 2021 Jan 10, 2022	SELL	$3.63 - $6.13 $47,280 - $79,843	-13,025 Reduced 72.26%	5,000 $19,000
Q3 2021 Oct 13, 2021	BUY	$5.5 - $7.41 $11,000 - $14,820	2,000 Added 12.48%	18,025 $118,000
Q2 2021 Jul 14, 2021	SELL	$4.35 - $6.35 $56,945 - $83,127	-13,091 Reduced 44.96%	16,025 $98,000
Q1 2021 Apr 12, 2021	BUY	$3.94 - $7.09 $4,003 - $7,203	1,016 Added 3.62%	29,116 $131,000
Q4 2020 Jan 19, 2021	BUY	$5.45 - $8.65 $33,245 - $52,765	6,100 Added 27.73%	28,100 $168,000
Q3 2020 Oct 09, 2020	BUY	$4.34 - $11.43 $52,080 - $137,160	12,000 Added 120.0%	22,000 $163,000
Q2 2020 Jul 10, 2020	BUY	$1.85 - $5.29 $18,500 - $52,900	10,000 New	10,000 $40,000

142

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $144M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.